Fever and Thrombocytopenia After Returning From Nigeria
A 41-year-old man presents to the emergency department at 22:00 with 4 days of fever up to 39.2°C, chills, headache, and myalgia. He returned 9 days ago from Lagos, Nigeria, and took no malaria prophylaxis. Laboratory shows platelets 68,000/µL, hemoglobin 10.8 g/dL, and creatinine 1.4 mg/dL. The rapid malaria antigen test is negative. The night technologist prepares Giemsa-stained thick and thin films from an EDTA blood sample and sees numerous ring-form trophozoites in the thin film, with a parasitemia of about 2.5%; no schizonts or banana-shaped gametocytes are seen. The thick film shows 8–12 trophozoites per oil immersion field. The laboratory does not have PCR on site.
1. How should the negative rapid antigen test be interpreted, and what immediate laboratory action is required?
Read the worked answer
Interpretation: A negative rapid antigen test does not rule out malaria. The test can be negative with low parasitemia, with a non-falciparum species, with prozone effect at very high antigen concentrations, or with Plasmodium falciparum isolates that lack the HRP2 antigen because of gene deletion. The microscopic finding of ring forms is more important than the antigen result in this setting.
Immediate action: Do not cancel or delay the malaria workup because the antigen test is negative. Examine the thick and thin films carefully, confirm the parasitemia, and call the clinician with a critical result. The patient has fever, thrombocytopenia, anemia, and a travel history compatible with malaria; treatment should not wait for species confirmation. Repeat the antigen test if it is part of the local algorithm, but do not use it to overrule a positive smear.
Additional immediate step: Prepare and examine a second set of films if the first is technically inadequate, and consider a buffy-coat or concentration method if parasitemia is low. If the laboratory cannot confirm the species, report the smear result as Plasmodium species and recommend urgent species confirmation by a reference laboratory or PCR. The clinician should be told that the smear is positive and that the antigen test is discordant.
2. How is parasitemia calculated from the thin film, and how should this result be reported? What follow-up smears are needed?
Read the worked answer
Calculation: On the thin film, count parasitized red blood cells while examining a defined number of red blood cells, or count parasites per high-power field and convert using the RBC count. A common approach is to count infected RBCs per 1,000 RBCs and express the result as a percentage. If 25 of 1,000 RBCs are infected, parasitemia is 2.5%. For a more precise result, count at least 200–500 parasites or examine enough fields to reach a stable estimate. On the thick film, parasites are counted per white blood cell or per oil immersion field; that method is useful when parasitemia is low, but the percentage is usually derived from the thin film.
Reporting: Report the result as a critical value: "Plasmodium species seen; parasitemia approximately 2.5%; immediate notification to clinician." Include the stage seen-ring-form trophozoites-and the absence of schizonts or gametocytes. Do not report a species unless the morphology is definitive. A 2.5% parasitemia is clinically significant and warrants urgent treatment.
Follow-up: Repeat thick and thin films every 12–24 hours until negative, according to the clinical protocol, because parasitemia can rise quickly. Follow-up is especially important in P. falciparum infection, where deterioration can be rapid. If the parasitemia increases or the patient develops complications, escalate immediately.
3. What pre-analytical and post-analytical issues could affect the diagnosis, and what additional testing would you request?
Read the worked answer
Pre-analytical issues: Use fresh EDTA blood and prepare films promptly; prolonged storage can alter parasite morphology and reduce recovery. Label the films with the collection time. If the patient has already received antimalarials, parasitemia may be reduced. A fingerstick sample can be used, but the film must be made correctly. The timing of collection matters: multiple collections over several hours may be needed if the first film is negative. The laboratory should also confirm that the patient has not received antibiotics that affect the blood stage.
Post-analytical issues: A negative antigen test can create false reassurance, especially if the laboratory cancels the smear or fails to call the positive result. Species misidentification is another risk: ring forms alone do not prove P. falciparum, and mixed infections occur. The report should distinguish "Plasmodium species" from a definitive species call.
Additional testing: Request PCR or a reference-laboratory malaria smear for species confirmation, especially if the patient has been treated or if the morphology is mixed. Test for P. falciparum drug-resistance markers only if locally available and clinically indicated. Monitor platelet count, hemoglobin, creatinine, and parasitemia. Consider other travel-associated infections such as dengue or typhoid, but do not delay malaria treatment while waiting for those results.